C12 β-D-galactosyl ceramide
| Catalog Number | BL-M000962 |
| CAS Number | 41613-14-3 |
| Description | C12 β-D-galactosyl ceramide, a glycosphingolipid molecule, exhibits significant implications in the realms of cell signaling and immunology. Its intricate structure has garnered interest in therapeutic avenues for combating diverse malignancies and autoimmune conditions, showcasing promising potential in the biomedical landscape. |
 | |
| IUPAC Name | N-[(E,2S,3R)-3-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]dodecanamide |
| Synonyms | C12 beta-GalCer; C12 Galactosyl(β) Ceramide (d18:1/12:0); beta-D-galactosyl-N-(dodecanoyl)sphingosine; D-galactosyl-β-1,1' N-lauroyl-D-erythro-sphingosine |
| Molecular Weight | 643.94 |
| Molecular Formula | C36H69NO8 |
| Purity | >99% |
| Appearance | Powder |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 67.15%, H 10.80%, N 2.18%, O 19.88% |
| Canonical SMILES | CCCCCCCCCCCCCC=CC(C(COC1C(C(C(C(O1)CO)O)O)O)NC(=O)CCCCCCCCCCC)O |
| InChI | InChI=1S/C36H69NO8/c1-3-5-7-9-11-13-14-15-16-18-19-21-23-25-30(39)29(28-44-36-35(43)34(42)33(41)31(27-38)45-36)37-32(40)26-24-22-20-17-12-10-8-6-4-2/h23,25,29-31,33-36,38-39,41-43H,3-22,24,26-28H2,1-2H3,(H,37,40)/b25-23+/t29-,30+,31+,33-,34-,35+,36+/m0/s1 |
| InChI Key | IYCYEZLMOLRFAN-XSXRAWBPSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry
